Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Input: Consider Input: Paragraph: Costs of theMRIdian on-table adaptive radiotherapy in comparison to conventional radiotherapy are not discussed. Given that it is new and more personalized than current treatment options it's likely to be correspondingly more expensive. Certainly, more frequent MRIs would be very costly. The release provides exact information about increased survival rates in the cohorts of individuals treated with the adaptive versus the convention radiotherapy techniques. "The cohort receiving a higher dose demonstrated a near doubling of median overall survival (Kaplan-Meier estimated median overall survival of 27.8 months compared to 14.8 months)." The news release provides specific results regarding experiences of both groups with regard to toxicity from radiotherapy. We appreciate that the headline of this release starts with the words "early data" because this report deals with preliminary and retrospective research. It was not a clinical trial. Instead, results are based on retrospectively comparing treatment of two groups of patients at four institutions. Respective comparisons can't account for a host of factors that might influence results. At the end of the news release readers are told that on the basis of these promising results a clinical trial is being planned. With five-year survival rates of 1 to 14%, it would be hard to engage in disease mongering about pancreatic cancer. This research was sponsored by ViewRay, the company that developed the MRIdian system, and the release does a good job calling attention to this. However, according to the published study, at least one of the co-authors received honoraria from ViewRay Medical Systems. Since this was not included in the release we're rating this criteria Not Satisfactory. This study was all about comparing alternatives, so it scores Satisfactory on that criterion. It would have helped readers if alternatives would have been described more in laymen's terms. The news release notes that the next step is a prospective clinical trial and that tells savvy readers that this treatment strategy has a long road of testing ahead. Still, we think the release could have done a better job clarifying that this therapy is not yet ready for patients, outside of the clinical trial. A study that suggests a doubling of median survival is sure to capture the attention of patients newly diagnosed with pancreatic cancer. These patients and their families are closely aware of the glum statistics for the disease. This is a practical concern that the release should have touched on. This technology is indeed novel and unique to ViewRay, though it is becoming available in more and more cancer treatment centers. No unjustifiable language was identified in the news release. Claim: Early data shows nearly 2x prolonged median survival for inoperable pancreatic cancer

Output: This news release reports results of a retrospective study comparing conventional radiotherapy for inoperable pancreatic cancer versus an adaptive radiation therapy that allows clinicians to see the tumor in real time and respond to changes on a daily basis. Targeting the tumor more specifically means higher doses of radiation can be used without increasing damage to surrounding tissues. The study, funded by ViewRay, maker of the MRIdian system, is admittedly preliminary. It is to be followed up by a clinical trial. The release would have been more helpful to readers had it mentioned costs and disclosed a conflict of interest between one of the study authors and the device manufacturer. Surgery is an option only for certain less common types of pancreatic cancer. The five-year survival rates for pancreatic cancers that cannot be treated with surgery are 12% to 14% even for those diagnosed in stage I; the five-year survival rate for cancers detected at stage IV is about 1%, according to the American Cancer Society. ACS reminds readers that five-year survival rates are estimates and that "many people live longer often much longer than 5 years." In that context, a treatment that could extend the lives of the 1.5% of Americans who develop pancreatic cancer is big news.

Input: Consider Input: Paragraph: "President Barack Obama drew harsh criticism for comparing the terrorist group Islamic State to a ""JV team"" and then again for claiming that's not what he said (PolitiFact rated that statement False). On Sunday, another one of his characterizations of the situation in the Middle East came under fire as the political talk shows debated his plan for dealing with instability there. Former CIA and NSA director Michael Hayden was asked about Obama's decision to arm local rebel groups in Syria to help fight the Islamic State there. He wondered why Obama was suddenly interested in arming opposition forces there. ""The president referred to the Syrian opposition just a few months ago as pharmacists and doctors, and so on,"" Hayden said. ""We've turned on the dime in terms of our expectation for them, so if we're going to get them to this force that he said it was fantasy to rely on to the force that's going to be, as (White House Chief of Staff Denis McDonough) said, the anvil in a combined arms operation, they're going to need an awful lot of help."" In this case, we're checking whether Obama described theSyrian rebels as ""pharmacists and doctors."" We're not checking whether the rebels actually are pharmacists or doctors, as we'll explain in a bit. We tried to reach Hayden but were unsuccessful. McDonough, though, was asked about Obama's comment during an appearance on CNN's State of the Union. ""I think that the question that the president was responding to at the time was looking back a couple of years,"" McDonough said. ""We have had a relationship with these fighters now for a couple of years. They're getting better and more capable."" If that's the case, then maybe Hayden was embellishing Obama's comments. Keep in mind, the debate over arming the Syrian opposition forces in their fight against Syrian President Bashar al Assad has been ongoing for years. PolitiFact noted in a fact-check last week that several key members of Obama's national security team favored the move in August 2012. Let's take a look at exactly what Obama said. We found four instances of Obama describing the Syrian opposition forces in recent months. May 29 Obama discussed his foreign policy during an interview with NPR. He was asked if conditions were more ""robust"" for aiding the rebels than in the past. ""I wouldn't say the conditions are better,"" Obama said. ""In many ways, the conditions are worse. ""When you talk about the moderate opposition, many of these people were farmers or dentists or maybe some radio reporters who didn't have a lot of experience fighting,"" he added. ""But creating a capacity for them to hold ground, to be able to rebuff vicious attacks, for them to be able to also organize themselves in ways that are cohesive all that takes, unfortunately, more time than I think many people would like."" For what it's worth, the Washington Post fact-checked Obama's claim about the makeup of Syrian rebels as farmer, dentists and radio reporters and found it to be dubious. June 19 In mid June, a few days before Obama asked Congress for $500 million to train and equip some of the Syrian opposition, he discussed the makeup of those forces on a couple occasions. In a June 19 press conference, a reporter asked Obama if ""the expansion of the Syria war into Iraq changed your mind about the type of weapons and training we're now willing to give the opposition there?"" Obama responded: ""The question has always been, is there the capacity of moderate opposition on the ground to absorb and counteract extremists that might have been pouring in, as well as an Assad regime supported by Iran and Russia that outmanned them and was ruthless. ""And so we have consistently provided that opposition with support,"" Obama said. ""Oftentimes, the challenge is if you have former farmers or teachers or pharmacists who now are taking up opposition against a battle-hardened regime, with support from external actors that have a lot at stake, how quickly can you get them trained; how effective are you able to mobilize them. And that continues to be a challenge."" The next morning, he made a similar comment to CBS'This Morning. ""When you get farmers, dentists and folks who have never fought before going up against a ruthless opposition in Assad, the notion that they were in a position suddenly to overturn not only Assad but also ruthless, highly trained jihadists if we just sent a few arms is a fantasy."" Aug. 8 In a sitdown with New York Times columnist Thomas Friedman, Obama again was asked about why he chose not to arm the Syrian rebels. ""This idea that we could provide some light arms or even more sophisticated arms to what was essentially an opposition made up of former doctors, farmers, pharmacists and so forth, and that they were going to be able to battle not only a well-armed state but also a well-armed state backed by Russia, backed by Iran, a battle-hardened Hezbollah, that was never in the cards,"" Obama said. Counter to what McDonough said Sept. 14, Obama very much seems to be talking about the Syrian opposition in the present and the challenges in providing them with assistance and arms. This continued up until August. The one caveat that Hayden does not mention is the conversation was largely in the context of the opposition's capacity to go up against Assad and the Syrian regime, not their ability to fight a rogue terrorist organization like the Islamic State. Still, it is a noticeable about-face that as recently as August, Obama told Friedman he believed ""there's not as much capacity as you would hope"" for providing these individuals training. Our ruling In discussing Obama's decision to arm opposition forces in Syria, Hayden said, ""The president referred to the Syrian opposition just a few months ago as pharmacists and doctors, and so on."" We found several examples of Obama, as recently as June and August, characterizing the Syrian rebels as pharmacists and doctors, as well as dentists, radio reporters and teachers. Usually he was describing their capacity to fight Assad, but that doesn't make Hayden's point any less accurate." Claim: The president referred to the Syrian opposition just a few months ago as pharmacists and doctors, and so on.

Output: "In discussing Obama's decision to arm opposition forces in Syria, Hayden said, ""The president referred to the Syrian opposition just a few months ago as pharmacists and doctors, and so on."" We found several examples of Obama, as recently as June and August, characterizing the Syrian rebels as pharmacists and doctors, as well as dentists, radio reporters and teachers. Usually he was describing their capacity to fight Assad, but that doesn't make Hayden's point any less accurate."

Input: Consider Input: Paragraph: The rare condition can lead to loss of nerve and muscle control, and it can ultimately be fatal "This is a huge step forward for public health in Connecticut," said Department of Public Health Commissioner Renee D. Coleman-Mitchell. "The ability to screen newborns gives allows the medical community to diagnose a rare and potentially fatal genetic disorder such as Spinal Muscular Atrophy before symptoms are visible. It also gives medical providers an opportunity to recommend the best possible plan of care for families and their children." It's estimated that SMA afflicts one in 11,000 Connecticut residents. State legislation passed in 2019 required DPH to conduct newborn screening for the disorder, which was recently added to the Federal Advisory Committee on Heritable Disorders in Newborns and Children's Recommended Uniform Screening Panel. There are different types of SMA. Most children have SMA Type 1, which causes weakness and, without treatment, can deteriorate quickly and lead to death. There is no cure, but new treatments can slow or prevent symptoms from worsening. Claim: Connecticut now testing newborns for rare genetic disorder.
Output: Connecticut's public health laboratory has begun testing newborn babies for the genetic disorder Spinal Muscular Atrophy, complying with a new state law that took effect on Jan. 1.